-
EP3242939
European procedure
- EP About this file
- EP Legal status
- EP Federated register
- EP Event history
- EP Citations
- EP Patent family
- EP All documents
Extract from the Register of European Patents
EP About this file: EP3242939
| EP3242939 - DNA MOLECULES PRODUCING CUSTOM DESIGNED REPLICATING AND NON-REPLICATING NEGATIVE STRANDED RNA VIRUSES AND USES THERE OF [Right-click to bookmark this link] | Status | Examination is in progress Status updated on 02.09.2019 Database last updated on 19.10.2024 | |
| Former | Request for examination was made Status updated on 13.10.2017 | ||
| Former | The international publication has been made Status updated on 07.08.2017 | Most recent event Tooltip | 04.05.2024 | New entry: Reply to examination report | Applicant(s) | For all designated states Seagull BioSolutions Pvt. Ltd. 'Mandar' A3 Vineet Cooperative Housing Society Near Karve Statue Kothrud, Pune 411038 / IN | [2017/46] | Inventor(s) | 01 /
MURTHY, U.M. Sreenivasa Plot No. 5B House No. 3-91/3 New Nagole Colony Saroor Nagar Post Hyderabad - 500 035 / IN | 02 /
RANE, Shailendra Devicharan c/o. Devicharan Rane 537/87 Lane No. 7 New Futala Near Campus Square Amravati Road Nagpur - 440 033 Maharashtra / IN | 03 /
NADE, Manasi Sanjay c/o. Sanjay Nade Vishnu Bhuvan Flat No. 501 1191 Sadashiv Peth Limayewadi Pune - 411 030 Maharashtra / IN | 04 /
JOSHI, Vishwas Dattatraya 2A 204 Siddhachal Phase VI Pokharan Road 2 Thane - 400 610 Maharashtra / IN | [2017/46] | Representative(s) | Wilson, Justin Scott Withers & Rogers LLP 2 London Bridge London SE1 9RA / GB | [N/P] |
| Former [2017/46] | Simpson, Kirsty Mairi Withers & Rogers LLP 4 More London Riverside London SE1 2AU / GB | Application number, filing date | 16734976.0 | 04.01.2016 | [2017/46] | WO2016IN00004 | Priority number, date | IN2015MUM39 | 05.01.2015 Original published format: IN 39MU2015 | [2017/46] | Filing language | EN | Procedural language | EN | Publication | Type: | A2 Application without search report | No.: | WO2016110869 | Date: | 14.07.2016 | Language: | EN | [2016/28] | Type: | A2 Application without search report | No.: | EP3242939 | Date: | 15.11.2017 | Language: | EN | The application published by WIPO in one of the EPO official languages on 14.07.2016 takes the place of the publication of the European patent application. | [2017/46] | Search report(s) | International search report - published on: | IN | 06.10.2016 | (Supplementary) European search report - dispatched on: | EP | 17.09.2018 | Classification | IPC: | C12N15/45, C12N7/01 | [2017/46] | CPC: |
C12N15/86 (EP,GB,US);
A61P35/00 (EP,GB,US);
A61P37/04 (EP,US);
C12N2760/18421 (US);
C12N2760/18432 (EP,GB,US);
C12N2760/18433 (US);
C12N2760/18443 (EP,GB,US);
C12N2770/24123 (EP,GB,US);
C12N2770/24134 (EP,GB,US);
C12N2840/20 (EP,GB,US);
C12N2840/203 (GB);
C12N2840/206 (GB);
Y02A50/30 (EP)
(-)
| Designated contracting states | AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR [2017/46] | Title | German: | DNA-MOLEKÜLE ZUR HERSTELLUNG INDIVIDUELL GESTALTETER REPLIZIERENDER UND NICHT-REPLIZIERENDEN, NEGATIVSTRÄNGIGER RNA-VIREN UND VERWENDUNGEN DAVON | [2017/46] | English: | DNA MOLECULES PRODUCING CUSTOM DESIGNED REPLICATING AND NON-REPLICATING NEGATIVE STRANDED RNA VIRUSES AND USES THERE OF | [2017/46] | French: | MOLÉCULES D'ADN PRODUISANT DES VIRUS À ARN À BRIN NÉGATIF DE RÉPLICATION ET DE NON-RÉPLICATION DE CONCEPTION PERSONNALISÉE ET LEURS UTILISATIONS | [2017/46] | Entry into regional phase | 07.08.2017 | National basic fee paid | 07.08.2017 | Search fee paid | 07.08.2017 | Designation fee(s) paid | 07.08.2017 | Examination fee paid | Examination procedure | 07.08.2017 | Examination requested [2017/46] | 07.08.2017 | Date on which the examining division has become responsible | 29.03.2019 | Amendment by applicant (claims and/or description) | 05.09.2019 | Despatch of a communication from the examining division (Time limit: M06) | 16.03.2020 | Reply to a communication from the examining division | 07.10.2020 | Despatch of a communication from the examining division (Time limit: M04) | 16.02.2021 | Reply to a communication from the examining division | 29.03.2022 | Despatch of a communication from the examining division (Time limit: M04) | 05.08.2022 | Reply to a communication from the examining division | 04.01.2024 | Despatch of a communication from the examining division (Time limit: M04) | 03.05.2024 | Reply to a communication from the examining division | Fees paid | Renewal fee | 13.02.2018 | Renewal fee patent year 03 | 30.01.2019 | Renewal fee patent year 04 | 31.01.2020 | Renewal fee patent year 05 | 15.01.2021 | Renewal fee patent year 06 | 25.01.2022 | Renewal fee patent year 07 | 17.01.2023 | Renewal fee patent year 08 | 29.12.2023 | Renewal fee patent year 09 | Penalty fee | Additional fee for renewal fee | 31.01.2018 | 03 M06 Fee paid on 13.02.2018 |
| Opt-out from the exclusive Tooltip competence of the Unified Patent Court | See the Register of the Unified Patent Court for opt-out data | ||
| Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court. | Documents cited: | Search | [XI]EP1217891 (MAYO FOUNDATION [US]) [X] 1,2,4 * the whole document * * in particular par. 2 and example 3, par. 159-161. * [I] 3,5-10,12-14; | [A]WO03072725 (SINAI SCHOOL MEDICINE [US], et al) [A] 1-10,12-14 * the whole document * * in particular paragraphs 024, 029, 034 and 074. *; | [XI]WO2004076619 (PASTEUR INSTITUT [FR], et al) [X] 15 * the whole document * * in particular example 2, items 4) and 5) and Fig. 9 * [I] 11; | [A] - FELIPE DE P, "POLYCISTRONIC VIRAL VECTORS", CURRENT GENE THE, BENTHAM SCIENCE PUBLISHERS LTD, NL, (20020101), vol. 2, no. 3, doi:10.2174/1566523023347742, ISSN 1566-5232, pages 355 - 378, XP008045198 [A] 1-10,12-14 * the whole document * * in particular abstract * DOI: http://dx.doi.org/10.2174/1566523023347742 | [AD] - GROSSARDT CHRISTIAN ET AL, "Granulocyte-macrophage colony-stimulating factor-armed oncolytic measles virus is an effective therapeutic cancer vaccine", HUMAN GENE THERAPY, LIEBERT, US, (20130701), vol. 24, no. 7, doi:10.1089/HUM.2012.205, ISSN 1043-0342, pages 644 - 654, XP002738901 [AD] 1-10,12-14 * abstract * DOI: http://dx.doi.org/10.1089/HUM.2012.205 | [AD] - A.D. HARTKOPF ET AL, "Enhanced killing of ovarian carcinoma using oncolytic measles vaccine virus armed with a yeast cytosine deaminase and uracil phosphoribosyltransferase", GYNECOLOGIC ONCOLOGY, (20130801), vol. 130, no. 2, doi:10.1016/j.ygyno.2013.05.004, ISSN 0090-8258, pages 362 - 368, XP055104463 [AD] 1-10,12-14 * abstract * DOI: http://dx.doi.org/10.1016/j.ygyno.2013.05.004 | [IDA] - BRANDLER SAMANTHA ET AL, "Pediatric measles vaccine expressing a dengue antigen induces durable serotype-specific neutralizing antibodies to dengue virus", PLOS NEGLECTED TROPICAL DISEASES, PUBLIC LIBRARY OF SCIENCE, US, vol. 1, no. 3, doi:10.1371/JOURNAL.PNTD.0000096, ISSN 1935-2735, (20070101), page E96, (20070101), XP002586513 [ID] 11,15 * abstract * * page 2 col. 1 par. 1 and col. 2 par. 3 * [A] 1-10,12-14 DOI: http://dx.doi.org/10.1371/JOURNAL.PNTD.0000096 | [XI] - Rowida Abdelgalel, "Expression of Dengue virus envelope glycoproteins using a Measles vaccine vector", THESIS, ARIZONA STATE UNIVERSITY, (20031201), pages 1 - 123, URL: https://repository.asu.edu/attachments/126009/content/Abdelgalel_asu_0010N_13482.pdf, (20180906), XP055504984 [X] 15 * the whole document * * in particular page 60 line 5- page 62 last full paragraph; Figure 16; page 73, Fig. 19 * [I] 11 | International search | [XY]WO9610400 (UAB RESEARCH FOUNDATION [US]) [X] 1-6 & 8 * abstract; page 13, para 2; page 5, summary of invention, para 2; table 1. whole document. * [Y] 7, 9-46, 48- 50; | [Y]WO2008118369 (DENDREON CORP [US], et al) [Y] 1-46, 48-50 * para [0020]. *; | [Y]WO2012022495 (LAUER ULRICH M [DE], et al) [Y] 1-46, 48-50* abstract. *; | [Y]WO2013046216 (JOSHI VISHWAS [IN]) [Y] 1-46, 48-50 * para [0024]; claims, whole document. * |